Healthcare major Abbott has decided to withdraw two types of stents from the Indian market in the wake of drug price regulator National Pharmaceutical Pricing Authority's (NPPA's) move to cap the prices.
The company has applied to the NPPA seeking to withdraw two kinds of stents.
An Abbott spokesperson said that following the NPPA's price ceiling decision, it "examined and re-examined" whether there is a sustainable way to make available two of the latest stent technologies in India.
The company took into consideration Alpine drug-eluting and the Absorb dissolving stents' higher manufacturing costs and other associated costs.
"We have determined it is not sustainable, and we have applied to the NPPA to withdraw these two stents," the spokesperson told PTI in an e-mailed statement.
The company said that presently, only a very small percentage of patients in India receive Alpine and Absorb stents.